Vimarsana
Biggest News Aggregation in the World

Page 24 - Brian Strom News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Brian Strom. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Brian Strom Today - Breaking & Trending Today

Dr. Andrew Brooks, Rutgers scientist who developed first COVID spit test, passes away, school announces - Vimarsana News

Dr. Andrew Brooks, Rutgers scientist who developed first COVID spit test, passes away, school announces

A Rutgers scientist who was a crucial figure in developing the first COVID-19 saliva-based test died unexpectedly Saturday.

Source: kristv.com
Rutgers professor Andrew Brooks, who pioneered COVID-19 saliva test, dies at 51 - Vimarsana News

Rutgers professor Andrew Brooks, who pioneered COVID-19 saliva test, dies at 51

The university did not disclose the cause of professor Andrew Brooks' death. He was 51. "We at Rutgers offer our heartfelt condolences to his family, including his three children, and with them we take pride in his achievements that will have lasting impact," said Rutgers-New Brunswick Chancellor Christopher J. Malloy, Chancellor Brian Strom and Vice President of Research S. David Kimball, in a joint statement. Gov. Phil Murphy called Brooks "one of our state's unsung heroes," and the test "undoubtedly saved lives," during his press briefing Monday. "We cannot thank Andy enough for all he did...

Mourning the Death of Rutgers' Andrew Brooks, a Leader in the Fight Against COVID-19 - Vimarsana News

Mourning the Death of Rutgers' Andrew Brooks, a Leader in the Fight Against COVID-19

The pioneering researcher who led the development of the first approved coronavirus saliva test died unexpectedly on Saturday.

Rutgers Scientist Who Developed COVID Spit Test Dies at 51 - Vimarsana News

Rutgers Scientist Who Developed COVID Spit Test Dies at 51

At the time, Brooks said the "impact of this approval is significant." "It means we no longer have to put health care professionals at risk for infection by performing nasopharyngeal or oropharyngeal collections. We can preserve precious personal protective equipment for use in patient care instead of testing," he said in a statement shared by Rutgers. "Saliva testing will help with the global shortage of swabs for sampling and increase testing of patients, and it will not require health care professionals to be put at risk to collect samples," Brooks continued. "Saliva testing will also be ...

Source: health.com